CN Patent

CN108143733B — 一种麻醉镇痛药物组合物及其制备方法

Assigned to Yichang Humanwell Pharmaceutical Co Ltd · Expires 2020-12-25 · 5y expired

What this patent protects

本发明涉及一种麻醉镇痛药物组合物，包含可作为镇静催眠药的包含瑞马唑仑及其衍生物与麻醉镇痛剂的复方药物组合物。

USPTO Abstract

本发明涉及一种麻醉镇痛药物组合物，包含可作为镇静催眠药的包含瑞马唑仑及其衍生物与麻醉镇痛剂的复方药物组合物。

Drugs covered by this patent

remimazolam-besylate (REMIMAZOLAM BESYLATE)

Patent Metadata

Patent number: CN108143733B
Jurisdiction: CN
Classification: —
Expires: 2020-12-25
Drug substance claim: No
Drug product claim: No
Assignee: Yichang Humanwell Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.